会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
    • 使用雾化环孢素预防和治疗肺部疾病
    • US08158110B2
    • 2012-04-17
    • US12433231
    • 2009-04-30
    • Aldo T. IaconoGriffith Bartley
    • Aldo T. IaconoGriffith Bartley
    • A61K9/14A61K9/12A61K38/00A61K38/12
    • A61K38/13A61K9/0073Y10T428/2982A61K2300/00
    • The present invention relates to methods and compositions for prevention of graft rejection in lung transplant recipients and for treatment of subjects with pulmonary disorders. Specifically, the methods and compositions of the invention provide a means for inhibiting immune response mediated inflammatory processes in the lungs. The method of the invention comprises the administration of aerosolized cyclosporine for prevention of acute and/or chronic refractory rejection in lung transplant patients. The invention further provides for the use of aerosolized cyclosporine to treat subjects having immunologically mediated inflammatory pulmonary disorders including, but not limited to, asthma, cystic fibrosis, idiopathic pulmonary fibrosis, chronic bronchitis and allergic rhinitis. The present invention, by enabling a method for the use of aerosolized cyclosporine for inhibiting pulmonary inflammation leading to prevention of graft rejection and treatment of pulmonary disorders, provides a safer and less toxic treatment than those methods that utilize systemic administration of cyclosporine.
    • 本发明涉及用于预防肺移植受体中的移植物排斥反应的方法和组合物以及用于治疗患有肺部疾病的受试者。 具体地,本发明的方法和组合物提供了一种用于抑制肺中免疫应答介导的炎症过程的手段。 本发明的方法包括施用雾化的环孢菌素以预防肺移植患者的急性和/或慢性难治性排斥反应。 本发明还提供了使用雾化的环孢菌素来治疗具有免疫介导的炎症性肺病的受试者,包括但不限于哮喘,囊性纤维化,特发性肺纤维化,慢性支气管炎和过敏性鼻炎。 本发明通过实现气雾化环孢菌素用于抑制肺部炎症导致预防移植物排斥反应和治疗肺部疾病的方法,提供比利用全身施用环孢菌素的那些方法更安全和更少毒性的治疗方法。